EFFECTS OF SONICATION ON SIZE DISTRIBUTION AND ENTRAPMENT OF LYNESTRENOL TRANSFEROSOME
DOI:
https://doi.org/10.22159/ijap.2020.v12s1.FF053Keywords:
Transferosome, Transdermal drug delivery system, Sonication, ynestrenolAbstract
Objective: The aim of this study was to develop transferosome vesicles for the transdermal drug delivery of lynestrenol.
Methods: The lynestrenol transferosome vesicle was made by encapsulating the drug in a variation of phosphatidylcholine and Tween 80 by the thinlayer
hydration method. The resulting transferosome vesicles were modified with a time variation of 30, 60, 90, and 120 min, and sonication variations
were paused and not paused. Particle size evaluation, polydispersity (PDI), and entrapment efficiency (%EE) were carried out on the variation of
sonication time.
Results: The evaluation results showed that sonication without pauses showed better %EE and particle size than sonication with pauses and
increasing concentration of Tween 80 (edge activator). The %EE increased, and particle size decreased with increasing sonication time; PDI of vesicles
was heterogeneous with increasing sonication time. The %EE in formulas F1 and F2 after 120 min was 73.06% and 76.06% (paused) and 80.40% and
82.97% (without paused). The particle size of formula F1 and F2 after 120 min 575.4 nm and 471.6 nm (paused) and 524.1 nm and 434.7 nm (without
paused). The PDI formulas of F1 and F2 after 120 min were 0.69 and 0.763 (paused) and 0.84 and 0.59 (without paused).
Conclusion: Based on the results of the transferosome vesicle characteristics, it was shown that the optimal vesicle composition for packaging
lynestrenol was vesicles that were composed of phosphatidylcholine and Tween 80 without pauses and could potentially be used as a transdermal
drug delivery system.
Downloads
References
revolution in drug delivery technology. Int J Pharm Sci Res 2010;1:1-2.
2. Jain CP, Vyas SP, Dixit VK. Niosomal system for delivery of rifampicin
to lymphatics. Int J Pharma Sci 2006;68:5758.
3. Baroli B, Ennas MG, Loffredo F, Isola M, Pinna R, López-Quintela MA.
Penetration of metallic nanoparticles in human full-thickness skin. J
Invest Dermatol 2007;127:1701-12.
4. Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W, et al.
Nanoparticles and microparticles for skin drug delivery. Adv Drug
Deliv Rev 2011;63:470-91.
5. Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA. Variables
influencing interactions of untargeted quantum dot nanoparticles with
skin cells and identification of biochemical modulators. Nano Lett
2007;7:1344-8.
6. Benson HA. Transfersomes for transdermal drug delivery. Expert Opin
Drug Deliv 2006;3:727-37.
7. Cevc G, Blume G. New, highly efficient formulation of diclofenac for
the topical, transdermal administration in ultradeformable drug carriers,
transfersomes. Biochim Biophys Acta 2001;1514:191-205.
8. Iskandarsyah I, Alvina WP, Ernysagita E. Penetration test of caffein
in ethosome and desmosome gel using an in vitro method. Int J Appl
Pharm 2017;9:1.
9. Anggraini W, Erny S, Iskandarsyah I. Effect of hifrophilicity surfactant
toward characterization and in vitro transfersomes penetration in gel
using Franz diffusion test. Int J Appl Pharm 2017;9:1.
10. Reza MI, Divya G, Rahul KG, Musarrat HW. Formulation of
ketoconazole loaded nano dispersive gel using swollen micelles
technique and its in vitro characterization. Int J Pharm Pharm Sci
2018;10:162-6.
11. Nurleli N, Iskandarsyah I, Ahmad A. Formulation and penetration
testing of ethosome azelaic acid on abdomen skin white rats
(Rattus norvegicus) with franz diffusion cell. Int Pharm Clin Res
2018;11:327-30.
12. Dhamecha DL, Rathi AA, Saifee M, Lahoti SR, Dehghan MH. Drug
vehicle based approaches of penetration enhancement. Int J Pharm
Pharm Sci 2009;1:24-46.
Published
How to Cite
Issue
Section
